550 likes | 756 Views
HEART-LUNG TRANSPLANTATION. Overall. ISHLT. 2012. J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095. NUMBER OF HEART-LUNG TRANSPLANTS REPORTED BY YEAR.
E N D
HEART-LUNG TRANSPLANTATION Overall ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
NUMBER OF HEART-LUNG TRANSPLANTS REPORTED BY YEAR NOTE: This figure includes only the heart-lung transplants that are reported to the ISHLT Transplant Registry. As such, this should not be construed as evidence that the number of heart-lung transplants worldwide has declined in recent years. ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
AVERAGE CENTER VOLUMEHeart-Lung Transplants: January 1, 2000 - June 30, 2011 ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
DISTRIBUTION OF HEART-LUNG TRANSPLANTS BY LUNG CENTER VOLUMEHeart-Lung Transplants: January 1, 2000 - June 30, 2011 ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
HEART-LUNG TRANSPLANTATION Kaplan-Meier Survival for All Ages(Transplants: January 1982 - June 2010) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
HEART-LUNG TRANSPLANTATION Adult Recipients ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
DIAGNOSIS IN ADULT HEART-LUNG TRANSPLANTS (Transplants: January 1982 - June 2011) “Other” includes cancer, LAM, OB, bronchiectasis ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
DIAGNOSIS IN ADULT HEART-LUNG TRANSPLANTS (Transplants: January 1982 - June 2011) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
DIAGNOSIS IN ADULT HEART-LUNG TRANSPLANTS BY ERA (Transplants: January 1982 - June 2011) “Other” includes OB (non-ReTX) and Bronchiectasis ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
ADULT HEART-LUNG TRANSPLANTSMajor Indications By Year (%) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
ADULT HEART-LUNG TRANSPLANTSMajor Indications By Year (Number) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
ADULT HEART-LUNG TRANSPLANTSAge Distribution By Location (Transplants: January 2000 - June 2011) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
ADULT HEART-LUNG TRANSPLANTSDiagnosis Distribution By Location(Transplants: January 2000 - June 2011) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
ADULT HEART-LUNG TRANSPLANTSDonorAge Distribution By Location(Transplants: January 2000 - June 2011) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
ADULT HEART-LUNG TRANSPLANTSKaplan-Meier Survival (Transplants: January 1982 - June 2010) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
ADULT HEART-LUNG TRANSPLANTS Kaplan-Meier Survival by Era (Transplants: January 1982 - June 2010) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
ADULT HEART-LUNG TRANSPLANTSKaplan-Meier Survival By Diagnosis (Transplants: January 1990 - June 2010) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
ADULT HEART-LUNG TRANSPLANTSKaplan-Meier Survival By Diagnosis Conditional on Survival to 1 Year (Transplants: January 1990 - June 2010) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
ADULT HEART-LUNG RECIPIENTS Cross-Sectional Analysis Functional Status of Surviving Recipients (Follow-ups: April 1994 – June 2011) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
ADULT HEART-LUNG RECIPIENTS Functional Status of Surviving Recipients US Recipients Only(Follow-ups: March 2005 – June 2011) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
ADULT HEART-LUNG RECIPIENTS Employment Status of Surviving Recipients(Follow-ups: April 1994 – June 2011) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
ADULT HEART-LUNG RECIPIENTS Rehospitalization Post-transplant of Surviving Recipients (Follow-ups: April 1994 – June 2011) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
ADULT HEART-LUNG RECIPIENTS Induction Immunosuppression(Transplants: January 2001 – June 2011) ISHLT Analysis is limited to patients who were alive at the time of the discharge 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
ADULT HEART-LUNG RECIPIENTS Induction Immunosuppression(Transplants: January 2000 – December 2010) ISHLT Analysis is limited to patients who were alive at the time of the discharge 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
ADULT HEART-LUNG RECIPIENTS Induction Immunosuppression(Transplants: January 2000 – December 2010) ISHLT Analysis is limited to patients who were alive at the time of the discharge 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
ADULT HEART-LUNG RECIPIENTS Maintenance Immunosuppression at Time of Follow-up (Follow-ups: January 2001 – June 2011) NOTE: Different patients are analyzed in Year 1 and Year 5 ISHLT Analysis is limited to patients who were alive at the time of the follow-up 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
ADULT HEART-LUNG RECIPIENTSMaintenance Immunosuppression Drug Combinations at Time of Follow-up (Follow-ups: January 2001 – June 2011) NOTE: Different patients are analyzed in Year 1 and Year 5 ISHLT Analysis is limited to patients who were alive at the time of the follow-up 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
POST-HEART-LUNG TRANSPLANT MORBIDITY FOR ADULTSCumulative Morbidity Rates in Survivors within 1 Year Post-Transplant (Follow-ups: April 1994 - June 2011) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
POST-HEART-LUNG TRANSPLANT MORBIDITY FOR ADULTSCumulative Morbidity Rates in Survivors within 5 Years Post-Transplant (Follow-ups: April 1994 - June 2011) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
Freedom from Coronary Artery Vasculopathy and BronchiolitisObliterans SyndromeFor Adult Heart-Lung Recipients (Follow-ups: April 1994 – June 2011) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
Freedom from Coronary Artery Vasculopathy For Adult Heart-Lung Recipients By Diagnosis Type (Follow-ups: April 1994 – June 2011) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
Freedom from BronchiolitisObliterans SyndromeFor Adult Heart-Lung Recipients By Diagnosis Type (Follow-ups: April 1994 – June 2011) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
Freedom from Severe Renal Dysfunction*For Adult Heart-Lung Recipients (Follow-ups: April 1994 – June 2011) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
MALIGNANCY POST-HEART-LUNG TRANSPLANT FOR ADULTSCumulative Morbidity Rates in Survivors(Follow-ups: April 1994 – June 2011) * Recipients may have experienced more than one type of malignancy so sum of individual malignancy types may be greater than total number with malignancy. ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
Freedom from MalignancyFor Adult Heart-Lung Recipients(Follow-ups: April 1994 – June 2011) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
ADULT HEART-LUNG TRANSPLANT RECIPIENTSCause of Death (Deaths: January 1992 – June 2011) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
ADULT HEART-LUNG TRANSPLANT RECIPIENTSRelative Incidence of Leading Causes of Death(Deaths: January 1992 – June 2011) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
HEART-LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
AGE DISTRIBUTION OF PEDIATRIC HEART-LUNG RECIPIENTS (Transplants: January 1982 - June 2011) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
AGE DISTRIBUTION FOR DONORS OF PEDIATRIC HEART-LUNG RECIPIENTSTransplants: January 1982 - June 2011 ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
AGE DISTRIBUTION OF PEDIATRIC HEART-LUNG RECIPIENTS BY YEAR NOTE: This figure includes only the heart-lung transplants that are reported to the ISHLT Transplant Registry. As such, this should not be construed as evidence that the number of pediatric heart-lung transplants worldwide has declined in recent years. ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
AGE DISTRIBUTION OF PEDIATRIC HEART-LUNG RECIPIENTS BY ERA OF TRANSPLANT ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
NUMBER OF CENTERS REPORTING PEDIATRIC HEART-LUNG TRANSPLANTS ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
NUMBER OF CENTERS REPORTING PEDIATRIC HEART-LUNG TRANSPLANTSStratified by center volume ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
DIAGNOSIS IN PEDIATRIC HEART-LUNG TRANSPLANT RECIPIENTS (Transplants: 1986-2010) “Other” includes Bronchiectasis, Alpha-1, and OB (non-ReTX) ISHLT NOTE: Unknown diagnoses were excluded from this tabulation. 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
PEDIATRIC HEART-LUNG TRANSPLANTSAge Distribution By Location (Transplants: January 2000 – June 2011) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
PEDIATRIC HEART-LUNG TRANSPLANTSDiagnosis Distribution By Location(Transplants: January 2000 – June 2011) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
PEDIATRIC HEART-LUNG TRANSPLANTSDonorAge Distribution By Location(Transplants: January 2000 – June 2011) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
PEDIATRIC HEART-LUNG TRANSPLANTSKaplan-Meier Survival By Diagnosis (Transplants: January 1990 - June 2010) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095
PEDIATRIC HEART-LUNG TRANSPLANTSKaplan-Meier Survival (Transplants: January 1982 - June 2010) ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095